Central Japan Railway Company (TYO:9022)

Theseus Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	353,823	259,468	740,983	674,640	331,651	340,509
Short-Term Investments	63,000	197,900	214,300	177,500	328,500	389,600
Cash & Short-Term Investments	416,823	457,368	955,283	852,140	660,151	730,109
Cash Growth	-46.09%	-52.12%	12.10%	29.08%	-9.58%	-3.92%
Accounts Receivable	197,412	210,621	181,591	140,989	98,656	102,146
Receivables	197,412	210,621	181,591	140,989	98,656	102,146
Inventory	47,258	41,775	41,858	37,337	34,369	41,938
Restricted Cash	-	1,090,759	1,351,634	1,585,282	1,813,068	2,076,158
Other Current Assets	1,098,760	142,394	260,731	96,537	76,520	73,481
Total Current Assets	1,760,253	1,942,917	2,791,097	2,712,285	2,682,764	3,023,832
Property, Plant & Equipment	6,088,266	6,058,783	5,808,861	5,612,601	5,407,662	5,176,757
Long-Term Investments	484,431	1,991,113	1,020,760	812,625	957,631	1,050,385
Other Intangible Assets	180,205	164,779	160,184	159,401	142,072	110,456
Long-Term Deferred Tax Assets	160,312	165,752	160,992	217,495	260,389	238,939
Other Long-Term Assets	1,595,890	1	2	2	1	1
Total Assets	10,269,357	10,323,345	9,941,896	9,514,409	9,450,519	9,600,370
Accounts Payable	65,388	83,397	85,332	79,533	75,970	70,084
Accrued Expenses	18,774	32,409	30,226	26,811	22,493	22,871
Short-Term Debt	38,413	35,147	32,094	27,341	30,738	29,993
Current Portion of Long-Term Debt	84,037	76,200	116,754	186,694	87,777	134,647
Current Income Taxes Payable	64,254	412,843	369,909	262,855	217,053	271,746
Other Current Liabilities	333,358	142,347	164,388	146,218	303,283	294,746
Total Current Liabilities	604,224	782,343	798,703	729,452	737,314	824,087
Long-Term Debt	4,694,597	4,196,751	4,216,377	4,243,191	4,327,396	4,269,623
Other Long-Term Liabilities	39,081	536,622	546,114	551,856	595,729	641,126
Total Liabilities	5,488,884	5,664,796	5,718,213	5,707,300	5,841,269	5,913,761
Common Stock	112,000	112,000	112,000	112,000	112,000	112,000
Additional Paid-In Capital	54,158	54,158	54,129	53,474	53,474	53,475
Retained Earnings	4,557,451	4,428,847	3,999,973	3,643,142	3,449,334	3,526,766
Treasury Stock	-124,148	-103,162	-103,161	-103,159	-103,159	-103,578
Comprehensive Income & Other	122,283	108,692	106,719	53,797	52,428	53,852
Total Common Equity	4,721,744	4,600,535	4,169,660	3,759,254	3,564,077	3,642,515
Minority Interest	58,729	58,014	54,023	47,855	45,173	44,094
Shareholders' Equity	4,780,473	4,658,549	4,223,683	3,807,109	3,609,250	3,686,609
Total Liabilities & Equity	10,269,357	10,323,345	9,941,896	9,514,409	9,450,519	9,600,370
Total Debt	4,817,047	4,308,098	4,365,225	4,457,226	4,445,911	4,434,263
Net Cash (Debt)	-4,400,224	-3,850,730	-3,409,942	-3,605,086	-3,785,760	-3,704,154
Net Cash Per Share	-4474.14	-3913.36	-3465.40	-3663.72	-3847.36	-3769.14
Filing Date Shares Outstanding	977.23	984	984	984	984	983.89
Total Common Shares Outstanding	977.23	984	984	984	984	983.89
Working Capital	1,156,029	1,160,574	1,992,394	1,982,833	1,945,450	2,199,745
Book Value Per Share	4831.74	4675.36	4237.48	3820.40	3622.05	3702.17
Tangible Book Value	4,541,539	4,435,756	4,009,476	3,599,853	3,422,005	3,532,059
Tangible Book Value Per Share	4647.34	4507.90	4074.69	3658.40	3477.66	3589.91

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.